HEALTH● LOWAug 26 · Aug 26, 2026, 11:09 PM
FDA approves new drug Rasonque to treat advanced pancreatic cancer
France 24 [en]
The US FDA on Wednesday approved Revolution Medicines' Rasonque for advanced pancreatic cancer, opening a new treatment option for patients with metastatic disease. A large trial found the once-daily pill doubled survival rates, offering fresh hope for people who have exhausted other treatments.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH44m agoPsychology says that adults who apologize for everything are not respectful people, but rather were forced to justify every decision as childrenClarínHEALTH58m agoThe painful news Zulma Lobato received about her health: "The state of her vision is very delicate"ClarínHEALTH2h agoCancer: Bricon Foundation donates N50m Bras, prostheses to 600 survivorsVanguard NigeriaHEALTH2h agoWomen health innovators face arduous path to successsouthcoastregister.com.au · Australia